Fresenius Medical Care to Share Research Findings at the American Society of Nephrology's Kidney Week

Presentations Include Catheter Reduction Program Results and Using Crit-Line to Monitor Fluid Removal Rates

WALTHAM, Mass. – October 26, 2011– At the American Society of Nephrology’s(ASN)Kidney Week 2011, Fresenius Medical Care, the nation’s leading provider of kidney dialysis services and renal products, is presenting research abstracts about dialysis treatment, patient care and outcomes. Fresenius Medical Care will highlight advances in areas critical to quality patient care, including its important catheter reduction efforts.

Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, and organizers are expecting more than 13,000 attendees, including more than 10,000 scientists and clinicians. The largest scientific gathering of kidney disease experts worldwide, Kidney Week is an opportunity for researchers to discuss important advances in the care of patients with kidney and related disorders.

Kidney Week 2011, the largest nephrology meeting of its kind, will provide a forum to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Fresenius Medical Care contributes research to ASN each year regarding the management of its patient population, to further the advancement of kidney care quality and patient outcomes.

Founded in 1966, the American Society of Nephrology (ASN) is the world’s largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.